Global Cord Blood Corporation - ADR

Name: Global Cord Blood Corporation - ADR Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Global Cord Blood Corporation - ADR

Stock Card

$1.13

$0.05 (4.63%)

As on 12-Jul-2023 09:30EDT

Market cap

$400 Mln

Revenue (TTM)

$1,225 Mln

P/E Ratio

5.1

P/B Ratio

0.6

Div. Yield

0 %

Value Research Rating

Quality Score

Growth Score

Valuation Score

Momentum Score

Know more

Explore 5 star rated stocks

Global Cord Blood - ADR Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 1.05 High: 1.20

52 Week Range

Low: -- High: --

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$365 Mln
ROE

0.1 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-0.8
Debt to Equity

0
Book Value

$--
EPS

$3.1
Face value

--
Shares outstanding

133,915,000

10 Years Aggregate

CFO

CN¥6,407.34 Mln

EBITDA

CN¥3,970.72 Mln

Net Profit

CN¥2,577.05 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Global Cord Blood - ADR	-62.2	-0.9	-62.2	-56.5	-30.6	-32.7	-10.3
BSE Sensex^*	-11.7	-4.8	1.1	-8.2	3.9	5.1	10.0
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 12-Jul-2023 | *As on 11-Sep-2026 | #As on 26-Oct-2023

Company	2022	2021	2020	2019	2018	2017	2016
Global Cord Blood - ADR	-28.6	12.9	-25.8	-22.5	-34.4	62.6	-3.9
S&P Small-Cap 600	-17.4	25.3	9.6	20.9	-9.7	11.7	24.7
BSE Sensex	4.4	22.0	15.8	14.4	5.9	27.9	1.9

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Shareholding Pattern

View Details

About Global Cord Blood - ADR

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction... of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd. Read more

CEO & CEO of Beijing Division

Ms. Ting Zheng
Chief Financial Officer

Mr. Bing Chuen Chen
Headquarters

Central
Website

https://www.globalcordbloodcorp.com

FAQs for Global Cord Blood - ADR

What is the current share price of Global Cord Blood Corporation - ADR Today?

The share price of Global Cord Blood Corporation - ADR is $1.13 (NYSE) as of 12-Jul-2023 09:30 EDT. Global Cord Blood Corporation - ADR has given a return of -30.6% in the last 3 years.

What is the current PB & PE ratio of Global Cord Blood Corporation - ADR?

The P/E ratio of Global Cord Blood Corporation - ADR is 5.06 times as on 19-May-2023.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2022	0.94	0.10
2021	1.08	0.13
2020	0.82	0.10
2019	2.97	0.25
2018	5.25	0.40

What is the 52 Week High and Low of Global Cord Blood Corporation - ADR?

The 52-week high and low of Global Cord Blood Corporation - ADR are Rs -- and Rs -- as of 13-Sep-2026.

What is the market cap of Global Cord Blood Corporation - ADR?

Global Cord Blood Corporation - ADR has a market capitalisation of $ 400 Mln as on 19-May-2023. As per SEBI classification, it is a Small Cap company.

Should I invest in Global Cord Blood Corporation - ADR?

Before investing in Global Cord Blood Corporation - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.